Lactic Acid Bacteria that Detect & Inhibit Enterococci in the Mammalian GI Tract

检测的乳酸菌

基本信息

  • 批准号:
    8747170
  • 负责人:
  • 金额:
    $ 35.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Enterococci are bacteria that grow naturally inside human intestines. Over the last few decades, these pathogens have developed resistance to our most potent antibiotics, including vancomycin, an antibiotic of last resort for infectious disease. Vancomycin-resistant Enterococcus (VRE) does not cause illness to healthy individuals. But it does cause severe illness to hospital patients, especially the ones who have undergone antibiotic therapy. Antibiotic therapy eliminates a lot of the "good" bacteria in the gut of humans. VRE grab and fill this vacuum, spreading quickly from the intestines to the bloodstream and from there to the spleen, the liver, the heart. There they grow and cause disease that can no longer be easily treated with antibiotics. We genetically engineer lactic acid bacteria (LAB) to specifically target enterococcus inside gastrointestinal (GI) tracts. We propose to administer these cellbots to mice and examine if enterococcus vanishes from mouse GI tracts. We pursue three specific aims: First we engineer "smart" LAB that can detect enterococci. Upon detection, engineered LAB produce and release proteins. In the second aim, we engineer these proteins to be lethal to enterococci. In the third aim, we will examine the efficacy of our modified LAB in mice. We will infect mice with enterococcus and then administer LAB to them. The main hypothesis is that engineered LAB kill enterococci and stop their colonization inside animal GI tracts. If successful, these experiments can lead to the development of a promising therapeutic strategy against enterococcal infections.
描述(申请人提供):肠球菌是在人体肠道内自然生长的细菌。在过去的几十年里,这些病原体已经对我们最有效的抗生素产生了抗药性,包括万古霉素,这是一种治疗传染病的最后手段。万古霉素耐药肠球菌(VRE)不会对健康个体造成疾病。但它确实会给医院的患者带来严重的疾病,特别是那些接受过抗生素治疗的患者。抗生素疗法消除了肠道中的许多“有益”细菌 人类的生命。VRE抓住并填补这个真空,从肠道迅速传播到血液,然后从那里传播到脾、肝和心脏。在那里,它们生长并导致疾病,不再容易地用抗生素治疗。我们通过基因工程改造乳酸 细菌(LAB),专门针对胃肠道(GI)内的肠球菌。我们建议给小鼠使用这些蜂窝机器人,并检查肠球菌是否从小鼠的胃肠道中消失。我们追求三个具体目标:首先,我们设计了能够检测肠球菌的“智能”实验室。一旦检测到,工程实验室就会产生并释放蛋白质。在第二个目标中,我们将这些蛋白质改造成对肠球菌具有致命性。在第三个目标中,我们将检查我们改进后的实验室在小鼠身上的效果。我们将用肠球菌感染小鼠,然后对它们进行实验室治疗。主要的假设是,经过改造的实验室杀死了肠球菌,并阻止它们在动物胃肠道内定居。如果成功,这些实验可能导致开发一种有希望的治疗策略来对抗肠球菌感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY M DUNNY其他文献

GARY M DUNNY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY M DUNNY', 18)}}的其他基金

Functional genomics analysis of colonization and persistence of Enterococcus faecalis in the gastrointestinal tract.
粪肠球菌在胃肠道中定植和持续存在的功能基因组学分析。
  • 批准号:
    9215645
  • 财政年份:
    2016
  • 资助金额:
    $ 35.3万
  • 项目类别:
Pathway for functional characterization of hypothetical genes and non-coding RNAs of Enterococcus faecalis
粪肠球菌假设基因和非编码 RNA 功能表征途径
  • 批准号:
    8986937
  • 财政年份:
    2015
  • 资助金额:
    $ 35.3万
  • 项目类别:
Lactic Acid Bacteria that Detect & Inhibit Enterococci in the Mammalian GI Tract
检测的乳酸菌
  • 批准号:
    9060971
  • 财政年份:
    2014
  • 资助金额:
    $ 35.3万
  • 项目类别:
Lactic Acid Bacteria that Detect & Inhibit Enterococci in the Mammalian GI Tract
检测的乳酸菌
  • 批准号:
    9272922
  • 财政年份:
    2014
  • 资助金额:
    $ 35.3万
  • 项目类别:
Invasion and Exclusion by Enterococcus faecalis in the Manduca gut community
粪肠球菌对天蛾肠道群落的入侵与排除
  • 批准号:
    8412944
  • 财政年份:
    2012
  • 资助金额:
    $ 35.3万
  • 项目类别:
4th ASM Conference on Cell-Cell Communication in Bacteria
第四届 ASM 细菌细胞间通讯会议
  • 批准号:
    8205337
  • 财政年份:
    2011
  • 资助金额:
    $ 35.3万
  • 项目类别:
Biofilms and Enterococcus faecalis Biology
生物膜和粪肠球菌生物学
  • 批准号:
    8038029
  • 财政年份:
    2005
  • 资助金额:
    $ 35.3万
  • 项目类别:
Biofilms and Enterococcus faecalis Biology
生物膜和粪肠球菌生物学
  • 批准号:
    6968394
  • 财政年份:
    2005
  • 资助金额:
    $ 35.3万
  • 项目类别:
Biofilms and Enterococcus faecalis Biology
生物膜和粪肠球菌生物学
  • 批准号:
    8582526
  • 财政年份:
    2005
  • 资助金额:
    $ 35.3万
  • 项目类别:
Biofilms and Enterococcus faecalis Biology
生物膜和粪肠球菌生物学
  • 批准号:
    7226681
  • 财政年份:
    2005
  • 资助金额:
    $ 35.3万
  • 项目类别:

相似海外基金

Development of decellularized small-diameter arterial grafts and evaluation in large animal experiments
脱细胞小直径动脉移植物的研制及大动物实验评价
  • 批准号:
    21H03016
  • 财政年份:
    2021
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Developing and validating a computational model of the gut microbiota-mucosa interactions to replace and reduce animal experiments
开发和验证肠道微生物群-粘膜相互作用的计算模型,以取代和减少动物实验
  • 批准号:
    NC/R001707/1
  • 财政年份:
    2018
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Training Grant
Developing and validating a computational model of the gut microbiota-mucosa interactions to replace and reduce animal experiments
开发和验证肠道微生物群-粘膜相互作用的计算模型,以取代和减少动物实验
  • 批准号:
    2103295
  • 财政年份:
    2018
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Studentship
Research on the way of information transmission to gain social understanding of animal experiments
动物实验获得社会理解的信息传递方式研究
  • 批准号:
    16K07080
  • 财政年份:
    2016
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CDS&E: Modeling the Zebrafish Model Organism Toward Reducing, Refining, and Replacing Animal Experiments
CDS
  • 批准号:
    1505832
  • 财政年份:
    2015
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Standard Grant
Never replicate a successful experiment? Standardization, heterogenization and reproducibility in animal experiments
从未复制过成功的实验?
  • 批准号:
    283089959
  • 财政年份:
    2015
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Research Grants
Arrhythmogenic Drug Evaluation System by Simplified Animal Experiments
简化动物实验的致心律失常药物评价系统
  • 批准号:
    26350520
  • 财政年份:
    2014
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Promotion of the 4Rs in animal experiments by the development of a production process for polyclonal antibodies using a goldfish
开发金鱼多克隆抗体生产工艺,促进动物实验中的4R
  • 批准号:
    23650227
  • 财政年份:
    2011
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of microangiographic systems to visualize cerebular perforating artery in clinical settings and retrobulbar ophthalmic artery arteries in animal experiments.
开发显微血管造影系统,以在临床环境中可视化小脑穿支动脉,并在动物实验中可视化球后眼动脉。
  • 批准号:
    23390305
  • 财政年份:
    2011
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The study for the modification of cerebral synapses by balance exercises in the elderly based on animal experiments.
基于动物实验的老年人平衡运动改变大脑突触的研究。
  • 批准号:
    21500471
  • 财政年份:
    2009
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了